Cheri A. Pasch
机构:University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Wisconsin Division of Public Health · ORCID:0009-0005-9683-7378
发表论文 182 篇 · 总被引 964 次 · h-index 14
代表论文
- Suppression of the myofibroblastic cancer-associated fibroblast phenotype to enhance anti-PD-1 response (2026 · Journal of Experimental & Clinical Cancer Research)
- Clinical Trial Protocol from Tumor Matrix Proteoglycan Accumulation and Processing Alter T-cell Effector Function and the Response to Immunotherapy in Patients with Oligometastatic Colorectal Cancer (2026)
- Data from Tumor Matrix Proteoglycan Accumulation and Processing Alter T-cell Effector Function and the Response to Immunotherapy in Patients with Oligometastatic Colorectal Cancer (2026)
- Supplementary Figures S1-S14 from Tumor Matrix Proteoglycan Accumulation and Processing Alter T-cell Effector Function and the Response to Immunotherapy in Patients with Oligometastatic Colorectal Cancer (2026)
- Supplementary Tables S1-S6 from Tumor Matrix Proteoglycan Accumulation and Processing Alter T-cell Effector Function and the Response to Immunotherapy in Patients with Oligometastatic Colorectal Cancer (2026)
- Organoid Level Assessments of Human Primary and Metastatic Colorectal Cancer-Derived Organoids Predict Response to Chemotherapy and Chemoradiation (2026 · Cancers)